T326

CAS No. 1451042-19-5

T326( T 326 | HDAC3 inhibitor T326 )

Catalog No. M11945 CAS No. 1451042-19-5

A potent and selective HDAC3 inhibitor with IC50 of 0.26 uM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    T326
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent and selective HDAC3 inhibitor with IC50 of 0.26 uM.
  • Description
    A potent and selective HDAC3 inhibitor with IC50 of 0.26 uM, with no activity against HDAC1/4/6/8; induces dose-dependent selective increase of NF-κB acetylation in human colon cancer HCT116 cells, induces growth inhibition of cancer cells, and activates HIV gene expression in latent HIV-infected cells; shows promising activity for anticancer and antiviral benefits.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    T 326 | HDAC3 inhibitor T326
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    HDAC
  • Recptor
    HDAC
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1451042-19-5
  • Formula Weight
    434.474
  • Molecular Formula
    C21H18N6O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(C1=CC=C(C2=CN(CCC3=CC=CC([N+]([O-])=O)=C3)N=N2)S1)NC4=CC=CC=C4N
  • Chemical Name
    N-(2-aminophenyl)-5-(1-(3-nitrophenethyl)-1H-1,2,3-triazol-4-yl)thiophene-2-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Suzuki T, et al. PLoS One. 2013 Jul 16;8(7):e68669.
molnova catalog
related products
  • Class I and IIB HDAC...

    Class I and IIB HDAC inhibitor 42 is a novel potent, selective class I and IIB inhibitor.

  • MPT0E028

    MPT0E028 (MPT 0E028) is a potent HDAC inhibitor that inhibits nuclear HDAC activity with IC50 of 11.1 nM in HeLa cells.

  • Quisinostat

    Quisinostat (JNJ-26481585) is a novel second-generation HDAC inhibitor with highest potency for HDAC1 with IC50 of 0.11 nM, modest potent to HDACs 2, 4, 10, and 11.